24.11.2015 • News

Wanhua in Polyisocyanates Cooperation with Sapici

China’s Wanhua Chemical Group has entered into a distribution and tolling collaboration with Italy’s Sapici for aliphatic polyisocyanates.

Under the terms of the agreement, Sapici will warehouse and distribute Wanhua’s product range throughout Europe, the Middle East and Africa. Wanhua will also have access to Sapici’s manufacturing capacities and technical resources.

A manufacturer and marketer of raw materials for coatings and adhesives, Sapici has three production plants – two in Italy at Cernusco sul Naviglio, Milan, and San Cipriano Po, Pavia, and one in Zhuhai, Guangdong, China. The company invested a multi-million euro sum last year to expand capacity in San Cipriano Po and Zhuhai.

Christian Furiosi, Sapici’s CEO, said the partners will leverage the recent investment in isocyanate production and will continue to expand their portfolio.

Wanhua claims to be the largest MDI manufacturer in the world and the only Chinese company with independent intellectual property rights for making methylene diphenyl diisocyanate (MDI), hexamethylene diisocyanate (HMDI), and isophorone diisocyanate (IPDI).

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read